Company intelligence / Profile preview

PharmaPlus

Jackson, New Jersey, USApharmaplusspecialty.com ↗

Ownership: Private
Employees: ~14
Development stage: Phase 3

Overview

PharmaPlus operates as both a specialty pharmacy in the US and as an independent community pharmacy support organization in the UK. The US entity focuses on providing specialty medications for chronic illnesses, while the UK entity supports independent pharmacies with business and professional services.

Therapeutic areas: Other
Modalities: Not applicable (primarily pharmacy and healthcare support, not drug development)
Industry: Non-Academic Healthcare

Drug pipeline

3 assets

Generex Oral-lyn

Phase 3

Indications: Type 1 diabetes, Type 2 diabetes

2 more assets in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on PharmaPlus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaPlus.

Explore the full profile